Kyntra Bio (KYNB) Stock Price
Kyntra Bio Price
Revenue at Kyntra Bio has contracted by 16.4% per year over the past 13 years to 6.44 M USD. Kyntra Bio's net margin stands at 2,848.6%, up from -123.3% several years earlier.
Kyntra Bio stock price
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Kyntra Bio business model & stock analysis
Frequently asked questions about Kyntra Bio
9 analysts currently rate the Kyntra Bio stock: 7 recommend buying, 2 holding and 0 selling. For 2026, analysts expect Kyntra Bio to generate revenue of 6.71 M USD and earnings per share of -12.43 USD.
Converted at the current exchange rate, the Kyntra Bio share trades at 4.71 EUR (5.28 USD).
The Kyntra Bio share (KYNB) is listed on 6 stock exchanges, including: NASDAQ (FGEN), London (0IL8.L), SIX (Zürich) (1FG.SW), Frankfurt (1FG.F), Düsseldorf (1FG.DU).
The expected revenue of Kyntra Bio is 6.71 M USD. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Kyntra Bio is -50.26 M USD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Kyntra Bio is currently -0.42. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Kyntra Bio stock.
The price-to-sales ratio (P/S) of Kyntra Bio is currently 3.18. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Kyntra Bio stock.
The Eulerpool Quality Score for Kyntra Bio is 3/10.
The ISIN of Kyntra Bio is US31572Q8814. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of Kyntra Bio is A12EZ0. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of Kyntra Bio is KYNB. The ticker symbol is used to trade Kyntra Bio shares on the stock exchange.
Kyntra Bio stock
Kyntra Bio Peer Group
Kyntra Bio Ticker
All fundamentals and in-depth analysis of Kyntra Bio
Our stock analysis for Kyntra Bio stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Kyntra Bio. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.